Richard Reisdorph
Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 11 | 2025 | 727 | 1.250 |
Why?
| | Mass Spectrometry | 10 | 2025 | 750 | 1.010 |
Why?
| | Research | 2 | 2018 | 431 | 0.840 |
Why?
| | Proteomics | 10 | 2025 | 1195 | 0.770 |
Why?
| | Proteome | 6 | 2025 | 518 | 0.760 |
Why?
| | Aldehyde Dehydrogenase | 4 | 2006 | 99 | 0.560 |
Why?
| | Phosphopeptides | 1 | 2018 | 20 | 0.560 |
Why?
| | Peptide Mapping | 1 | 2018 | 63 | 0.560 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2006 | 269 | 0.550 |
Why?
| | Metabolome | 2 | 2020 | 384 | 0.540 |
Why?
| | Tyrosine | 1 | 2018 | 222 | 0.530 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2018 | 428 | 0.450 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 592 | 0.430 |
Why?
| | Lung | 2 | 2018 | 4109 | 0.420 |
Why?
| | Acidosis, Lactic | 2 | 2024 | 45 | 0.420 |
Why?
| | Chromatography, Liquid | 7 | 2025 | 454 | 0.410 |
Why?
| | Chromatography, High Pressure Liquid | 6 | 2025 | 598 | 0.400 |
Why?
| | Cysteine | 2 | 2024 | 210 | 0.370 |
Why?
| | Sulfhydryl Compounds | 2 | 2025 | 189 | 0.360 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2018 | 636 | 0.330 |
Why?
| | Mitochondrial Proteins | 2 | 2025 | 263 | 0.320 |
Why?
| | Tandem Mass Spectrometry | 6 | 2024 | 577 | 0.310 |
Why?
| | Ethanol | 3 | 2024 | 627 | 0.290 |
Why?
| | Methylcholanthrene | 2 | 2006 | 21 | 0.290 |
Why?
| | Analgesia | 1 | 2010 | 105 | 0.290 |
Why?
| | Cardiomyopathies | 2 | 2024 | 338 | 0.280 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 26 | 0.270 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2026 | 179 | 0.270 |
Why?
| | Lysine | 3 | 2024 | 302 | 0.260 |
Why?
| | Ions | 1 | 2026 | 71 | 0.240 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2024 | 97 | 0.240 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 372 | 0.230 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2025 | 4 | 0.230 |
Why?
| | Food Analysis | 1 | 2025 | 24 | 0.230 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2025 | 23 | 0.230 |
Why?
| | Leigh Disease | 1 | 2025 | 22 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.230 |
Why?
| | Laboratories | 1 | 2026 | 109 | 0.220 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2026 | 56 | 0.220 |
Why?
| | Serine | 1 | 2026 | 145 | 0.220 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.220 |
Why?
| | Tea | 1 | 2025 | 17 | 0.220 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 7 | 0.220 |
Why?
| | Sirtuin 3 | 2 | 2023 | 60 | 0.220 |
Why?
| | Glycine | 1 | 2026 | 187 | 0.210 |
Why?
| | Animals | 27 | 2026 | 38109 | 0.210 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.210 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.210 |
Why?
| | Paraffin Embedding | 1 | 2024 | 33 | 0.210 |
Why?
| | Oxidative Phosphorylation | 1 | 2025 | 210 | 0.210 |
Why?
| | Folic Acid | 1 | 2026 | 199 | 0.210 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.210 |
Why?
| | Kidney Tubules, Proximal | 1 | 2025 | 130 | 0.210 |
Why?
| | Formaldehyde | 1 | 2024 | 66 | 0.210 |
Why?
| | Saccharum | 1 | 2025 | 77 | 0.200 |
Why?
| | Silicon Dioxide | 1 | 2025 | 121 | 0.200 |
Why?
| | Niacinamide | 1 | 2024 | 86 | 0.200 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 28 | 0.200 |
Why?
| | Corneal Injuries | 1 | 2024 | 42 | 0.200 |
Why?
| | Mitochondria | 4 | 2025 | 984 | 0.190 |
Why?
| | Cholesterol | 2 | 2023 | 408 | 0.190 |
Why?
| | Mustard Gas | 1 | 2024 | 93 | 0.190 |
Why?
| | Acylation | 2 | 2019 | 30 | 0.180 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 104 | 0.180 |
Why?
| | Lipids | 2 | 2017 | 710 | 0.180 |
Why?
| | Nervous System Diseases | 1 | 2025 | 284 | 0.180 |
Why?
| | Cell Hypoxia | 2 | 2003 | 247 | 0.180 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 388 | 0.170 |
Why?
| | Bronchoalveolar Lavage | 2 | 2018 | 89 | 0.170 |
Why?
| | Ion Mobility Spectrometry | 2 | 2017 | 5 | 0.170 |
Why?
| | Mice | 16 | 2026 | 18365 | 0.170 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.160 |
Why?
| | Liquid-Liquid Extraction | 2 | 2018 | 14 | 0.160 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 318 | 0.160 |
Why?
| | Biomarkers | 6 | 2024 | 4275 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 86 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 131 | 0.160 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.150 |
Why?
| | Succinic Acid | 1 | 2019 | 42 | 0.150 |
Why?
| | Myofibrils | 1 | 2019 | 49 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 187 | 0.150 |
Why?
| | Acetylation | 3 | 2024 | 256 | 0.150 |
Why?
| | Food | 1 | 2020 | 149 | 0.140 |
Why?
| | Liposomes | 1 | 2020 | 250 | 0.140 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.140 |
Why?
| | Humans | 29 | 2026 | 144957 | 0.140 |
Why?
| | Nanoparticles | 1 | 2025 | 520 | 0.140 |
Why?
| | Cornea | 3 | 2024 | 155 | 0.140 |
Why?
| | Trypsin | 1 | 2018 | 76 | 0.140 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 653 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 285 | 0.130 |
Why?
| | Hypoxia | 2 | 2006 | 1199 | 0.130 |
Why?
| | Autoantigens | 2 | 2011 | 429 | 0.130 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2016 | 1129 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2003 | 1500 | 0.130 |
Why?
| | Receptors, Aryl Hydrocarbon | 3 | 2003 | 60 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 771 | 0.120 |
Why?
| | Oxidation-Reduction | 3 | 2025 | 1087 | 0.120 |
Why?
| | Workflow | 1 | 2018 | 185 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 485 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.120 |
Why?
| | Major Histocompatibility Complex | 1 | 2016 | 229 | 0.120 |
Why?
| | Phosphorylation | 2 | 2018 | 1733 | 0.110 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2016 | 364 | 0.110 |
Why?
| | C-Peptide | 1 | 2016 | 189 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 331 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 939 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 198 | 0.110 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2014 | 131 | 0.100 |
Why?
| | Xenobiotics | 2 | 2006 | 32 | 0.100 |
Why?
| | Mutation | 1 | 2025 | 4099 | 0.100 |
Why?
| | Mutation, Missense | 2 | 2025 | 340 | 0.100 |
Why?
| | Galectins | 1 | 2013 | 27 | 0.100 |
Why?
| | Oxidative Stress | 3 | 2025 | 1339 | 0.090 |
Why?
| | Male | 13 | 2026 | 72406 | 0.090 |
Why?
| | Asthma | 2 | 2017 | 1768 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 150 | 0.090 |
Why?
| | Protein Processing, Post-Translational | 2 | 2024 | 477 | 0.090 |
Why?
| | Pulmonary Emphysema | 1 | 2014 | 275 | 0.090 |
Why?
| | Software | 2 | 2013 | 692 | 0.090 |
Why?
| | Hypersensitivity | 2 | 2017 | 252 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2171 | 0.080 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2016 | 3890 | 0.080 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2011 | 48 | 0.080 |
Why?
| | Reactive Oxygen Species | 2 | 2025 | 621 | 0.080 |
Why?
| | Liver Neoplasms, Experimental | 2 | 2001 | 26 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 43 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 469 | 0.080 |
Why?
| | Rats | 3 | 2006 | 5614 | 0.080 |
Why?
| | Protein C | 1 | 2009 | 53 | 0.070 |
Why?
| | Computational Biology | 1 | 2013 | 681 | 0.070 |
Why?
| | Epithelium, Corneal | 2 | 1999 | 41 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2001 | 919 | 0.070 |
Why?
| | Cell Line | 3 | 2025 | 2882 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2013 | 4155 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2006 | 1126 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4569 | 0.070 |
Why?
| | Down-Regulation | 2 | 2001 | 627 | 0.060 |
Why?
| | Urinalysis | 2 | 2020 | 80 | 0.060 |
Why?
| | Smoking | 1 | 2014 | 1472 | 0.060 |
Why?
| | Mice, Inbred NOD | 3 | 2016 | 610 | 0.060 |
Why?
| | Luciferases | 1 | 2006 | 152 | 0.060 |
Why?
| | Response Elements | 1 | 2006 | 89 | 0.060 |
Why?
| | Liver | 2 | 2026 | 1888 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 383 | 0.060 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2157 | 0.060 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2026 | 13 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2323 | 0.060 |
Why?
| | Genes, Reporter | 1 | 2006 | 276 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3550 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 699 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 863 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 57 | 0.060 |
Why?
| | Electron Transport Complex IV | 1 | 2025 | 62 | 0.060 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 63 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2006 | 2832 | 0.050 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.050 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2003 | 19 | 0.050 |
Why?
| | Islets of Langerhans | 1 | 2011 | 833 | 0.050 |
Why?
| | Tissue Fixation | 1 | 2024 | 37 | 0.050 |
Why?
| | Transcription Factors | 2 | 2003 | 1742 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5997 | 0.050 |
Why?
| | Introns | 1 | 2024 | 254 | 0.050 |
Why?
| | Age of Onset | 1 | 2025 | 551 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 411 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2003 | 79 | 0.050 |
Why?
| | Actin Cytoskeleton | 1 | 2024 | 103 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 187 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2019 | 3125 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 53 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 392 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1371 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 648 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2025 | 559 | 0.050 |
Why?
| | Female | 7 | 2025 | 78376 | 0.050 |
Why?
| | Alleles | 1 | 2025 | 881 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2025 | 337 | 0.040 |
Why?
| | Dexamethasone | 1 | 2024 | 372 | 0.040 |
Why?
| | Actins | 1 | 2024 | 425 | 0.040 |
Why?
| | Feces | 1 | 2025 | 513 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 321 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 19 | 0.040 |
Why?
| | Sphingomyelins | 1 | 2020 | 22 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 652 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 509 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 57 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 60 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 76 | 0.040 |
Why?
| | Up-Regulation | 1 | 2003 | 852 | 0.040 |
Why?
| | Cell Cycle | 1 | 2003 | 597 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 124 | 0.040 |
Why?
| | Peptides | 2 | 2016 | 998 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 35928 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 148 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 63 | 0.040 |
Why?
| | Hippocampus | 1 | 2026 | 967 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 103 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 541 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 1034 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2003 | 629 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 337 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 493 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 242 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2025 | 936 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 260 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2016 | 2931 | 0.040 |
Why?
| | Species Specificity | 1 | 2020 | 574 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 50 | 0.040 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1998 | 115 | 0.040 |
Why?
| | Cobalt | 1 | 1998 | 53 | 0.030 |
Why?
| | Bacteria | 1 | 2025 | 889 | 0.030 |
Why?
| | Critical Illness | 1 | 2024 | 892 | 0.030 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 6 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 601 | 0.030 |
Why?
| | Binding Sites | 1 | 2020 | 1331 | 0.030 |
Why?
| | Glycerophospholipids | 1 | 2017 | 39 | 0.030 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 78 | 0.030 |
Why?
| | Proline | 1 | 2017 | 83 | 0.030 |
Why?
| | Sphingolipids | 1 | 2017 | 83 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 424 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 66 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1496 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 855 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1275 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 175 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1490 | 0.030 |
Why?
| | Arginine | 1 | 2017 | 262 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 311 | 0.030 |
Why?
| | Solid Phase Extraction | 1 | 2014 | 25 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 2276 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 88 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 109 | 0.030 |
Why?
| | Adult | 3 | 2025 | 40506 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1642 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 379 | 0.020 |
Why?
| | Education | 1 | 2013 | 104 | 0.020 |
Why?
| | Brain | 1 | 2026 | 2941 | 0.020 |
Why?
| | Muromegalovirus | 1 | 2013 | 23 | 0.020 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2013 | 29 | 0.020 |
Why?
| | Blood Pressure | 1 | 2020 | 1769 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6434 | 0.020 |
Why?
| | Receptors, Virus | 1 | 2013 | 96 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2013 | 97 | 0.020 |
Why?
| | Interleukin-12 | 1 | 2013 | 117 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 223 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3415 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 160 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11799 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Signal Transduction | 1 | 2003 | 5233 | 0.020 |
Why?
| | Infant | 1 | 2024 | 10039 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 224 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 29 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 110 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 66 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 118 | 0.020 |
Why?
| | Fibrinogen | 1 | 2009 | 177 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1982 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 102 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 401 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1486 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 249 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 710 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 1060 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2013 | 1167 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1839 | 0.010 |
Why?
| | Child | 1 | 2025 | 22657 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 893 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1990 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 66 | 0.010 |
Why?
| | Chickens | 1 | 2003 | 191 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 277 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 1022 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 758 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 940 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 422 | 0.010 |
Why?
| | Eye Proteins | 1 | 1999 | 91 | 0.010 |
Why?
| | Genomics | 1 | 2003 | 836 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2003 | 1462 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1786 | 0.010 |
Why?
| | Young Adult | 1 | 2009 | 14126 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|